Clinical Trials in Ohio

Showing 3221-3240 of 20,938 trials

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

NCT04486716

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis who are transitioning from aCD20 mAb therapy

Relapsing Multiple Sclerosis

Novartis Pharmaceuticals111 participantsStarted Oct 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Pomona, California, United States +17 more locations

COMPLETEDNA32 miles

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

NCT04452149

The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrated device diagnostic-based risk stratification algorithm to guide patient care in subjects with NYHA class II and III heart failure, and to demonstrate the safety of the Reveal LINQ™ system and procedure in the study population.

Heart Failure NYHA Class IIHeart Failure NYHA Class III

Medtronic Cardiac Rhythm and Heart Failure826 participantsStarted Sep 2020

Mesa, Arizona, United States • Jonesboro, Arkansas, United States • Mission Viejo, California, United States +50 more locations

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Find Trials by Condition in Ohio

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

PREVENT ALL ALS Study

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Liver Cirrhosis Network Cohort Study

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Sapphire 3 CTO Study

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

MAAT For Young Adult Cancer Survivors

RNS System LGS Feasibility Study

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV